Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1441 to 1447 of 1447 entries
Sorted by: Best Match Show Resources per page
Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers.

Journal of medical economics

Epstein RS, Weerasinghe RK, Parrish AS, Krenitsky J, Sanborn RE, Salimi T.
PMID: 34927520
J Med Econ. 2022 Jan-Dec;25(1):108-118. doi: 10.1080/13696998.2021.2020570.

AIMS: Chemotherapy-induced myelosuppression, which commonly exhibits as neutropenia, anemia, or thrombocytopenia, represents a substantial burden for patients with cancer that affects health-related quality of life and increases healthcare resource utilization (HCRU). We evaluated the burden of myelosuppression among chemotherapy-treated...

Cite
Epstein RS, Weerasinghe RK, Parrish AS, et al. Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers. J Med Econ. 2022;25(1):108-118doi: 10.1080/13696998.2021.2020570.
Epstein, R. S., Weerasinghe, R. K., Parrish, A. S., Krenitsky, J., Sanborn, R. E., & Salimi, T. (2022). Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers. Journal of medical economics, 25(1), 108-118. https://doi.org/10.1080/13696998.2021.2020570
Epstein, Robert S, et al. "Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers." Journal of medical economics vol. 25,1 (2022): 108-118. doi: https://doi.org/10.1080/13696998.2021.2020570
Epstein RS, Weerasinghe RK, Parrish AS, Krenitsky J, Sanborn RE, Salimi T. Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers. J Med Econ. 2022 Jan-Dec;25(1):108-118. doi: 10.1080/13696998.2021.2020570. PMID: 34927520.
Copy Download .nbib Format: NLM
Cooperative Photoinduced/Brønsted Acid Catalyzed Cycloaddition of Transient Thioaldehydes and .

Organic letters

Sachse F, Schneider C.
PMID: 33733788
Org Lett. 2021 Apr 02;23(7):2682-2686. doi: 10.1021/acs.orglett.1c00588. Epub 2021 Mar 18.

A cooperative, one-pot approach for the in situ generation and ensuing cycloaddition of thioaldehydes and

Cite
Sachse F, Schneider C. Cooperative Photoinduced/Brønsted Acid Catalyzed Cycloaddition of Transient Thioaldehydes and . Org Lett. 2021;23(7):2682-2686doi: 10.1021/acs.orglett.1c00588.
Sachse, F., & Schneider, C. (2021). Cooperative Photoinduced/Brønsted Acid Catalyzed Cycloaddition of Transient Thioaldehydes and . Organic letters, 23(7), 2682-2686. https://doi.org/10.1021/acs.orglett.1c00588
Sachse, Florian, and Schneider, Christoph. "Cooperative Photoinduced/Brønsted Acid Catalyzed Cycloaddition of Transient Thioaldehydes and ." Organic letters vol. 23,7 (2021): 2682-2686. doi: https://doi.org/10.1021/acs.orglett.1c00588
Sachse F, Schneider C. Cooperative Photoinduced/Brønsted Acid Catalyzed Cycloaddition of Transient Thioaldehydes and . Org Lett. 2021 Apr 02;23(7):2682-2686. doi: 10.1021/acs.orglett.1c00588. Epub 2021 Mar 18. PMID: 33733788.
Copy Download .nbib Format: NLM
Considerations for treatment duration in responders to immune checkpoint inhibitors.

Journal for immunotherapy of cancer

Marron TU, Ryan AE, Reddy SM, Kaczanowska S, Younis RH, Thakkar D, Zhang J, Bartkowiak T, Howard R, Anderson KG, Olson D, Naqash AR, Patel RB, Sachdev E, Rodriguez-Ruiz ME, Sheffer M, Church S, Fuhrman C, Overacre-Delgoffe A, Nguyen R, Florou V, Thaxton JE, Aggen DH, Guerriero JL.
PMID: 33653801
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001901.

Immune checkpoint inhibitors (ICIs) have improved overall survival for cancer patients, however, optimal duration of ICI therapy has yet to be defined. Given ICIs were first used to treat patients with metastatic melanoma, a condition that at the time...

Cite
Marron TU, Ryan AE, Reddy SM, et al. Considerations for treatment duration in responders to immune checkpoint inhibitors. J Immunother Cancer. 2021;9(3)doi: 10.1136/jitc-2020-001901.
Marron, T. U., Ryan, A. E., Reddy, S. M., Kaczanowska, S., Younis, R. H., Thakkar, D., Zhang, J., Bartkowiak, T., Howard, R., Anderson, K. G., Olson, D., Naqash, A. R., Patel, R. B., Sachdev, E., Rodriguez-Ruiz, M. E., Sheffer, M., Church, S., Fuhrman, C., Overacre-Delgoffe, A., Nguyen, R., Florou, V., Thaxton, J. E., Aggen, D. H., & Guerriero, J. L. (2021). Considerations for treatment duration in responders to immune checkpoint inhibitors. Journal for immunotherapy of cancer, 9(3), . https://doi.org/10.1136/jitc-2020-001901
Marron, Thomas U, et al. "Considerations for treatment duration in responders to immune checkpoint inhibitors." Journal for immunotherapy of cancer vol. 9,3 (2021). doi: https://doi.org/10.1136/jitc-2020-001901
Marron TU, Ryan AE, Reddy SM, Kaczanowska S, Younis RH, Thakkar D, Zhang J, Bartkowiak T, Howard R, Anderson KG, Olson D, Naqash AR, Patel RB, Sachdev E, Rodriguez-Ruiz ME, Sheffer M, Church S, Fuhrman C, Overacre-Delgoffe A, Nguyen R, Florou V, Thaxton JE, Aggen DH, Guerriero JL. Considerations for treatment duration in responders to immune checkpoint inhibitors. J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001901. PMID: 33653801; PMCID: PMC7929825.
Copy Download .nbib Format: NLM
Case Study Comparison: Limitations in Telehealth Relating to Poverty and Family Support.

Seminars in hearing

Jorgensen LE, Barrett RE.
PMID: 34381299
Semin Hear. 2021 May;42(2):158-164. doi: 10.1055/s-0041-1731696. Epub 2021 Aug 02.

Telehealth appointments have grown in popularity due to the COVID-19 global pandemic. Three cases presented in this article show several different perspectives where telehealth was utilized. For the first patient, appointments were successfully completed via telehealth; however, the patient's...

Cite
Jorgensen LE, Barrett RE. Case Study Comparison: Limitations in Telehealth Relating to Poverty and Family Support. Semin Hear. 2021;42(2):158-164doi: 10.1055/s-0041-1731696.
Jorgensen, L. E., & Barrett, R. E. (2021). Case Study Comparison: Limitations in Telehealth Relating to Poverty and Family Support. Seminars in hearing, 42(2), 158-164. https://doi.org/10.1055/s-0041-1731696
Jorgensen, Lindsey E, and Barrett, Rachel E. "Case Study Comparison: Limitations in Telehealth Relating to Poverty and Family Support." Seminars in hearing vol. 42,2 (2021): 158-164. doi: https://doi.org/10.1055/s-0041-1731696
Jorgensen LE, Barrett RE. Case Study Comparison: Limitations in Telehealth Relating to Poverty and Family Support. Semin Hear. 2021 May;42(2):158-164. doi: 10.1055/s-0041-1731696. Epub 2021 Aug 02. PMID: 34381299; PMCID: PMC8328545.
Copy Download .nbib Format: NLM
Facial expressions elicit multiplexed perceptions of emotion categories and dimensions.

Current biology : CB

Liu M, Duan Y, Ince RAA, Chen C, Garrod OGB, Schyns PG, Jack RE.
PMID: 34767768
Curr Biol. 2022 Jan 10;32(1):200-209.e6. doi: 10.1016/j.cub.2021.10.035. Epub 2021 Nov 11.

Human facial expressions are complex, multi-component signals that can communicate rich information about emotions,

Cite
Liu M, Duan Y, Ince RAA, et al. Facial expressions elicit multiplexed perceptions of emotion categories and dimensions. Curr Biol. 2021;32(1):200-209.e6doi: 10.1016/j.cub.2021.10.035.
Liu, M., Duan, Y., Ince, R. A. A., Chen, C., Garrod, O. G. B., Schyns, P. G., & Jack, R. E. (2022). Facial expressions elicit multiplexed perceptions of emotion categories and dimensions. Current biology : CB, 32(1), 200-209.e6. https://doi.org/10.1016/j.cub.2021.10.035
Liu, Meng, et al. "Facial expressions elicit multiplexed perceptions of emotion categories and dimensions." Current biology : CB vol. 32,1 (2022): 200-209.e6. doi: https://doi.org/10.1016/j.cub.2021.10.035
Liu M, Duan Y, Ince RAA, Chen C, Garrod OGB, Schyns PG, Jack RE. Facial expressions elicit multiplexed perceptions of emotion categories and dimensions. Curr Biol. 2022 Jan 10;32(1):200-209.e6. doi: 10.1016/j.cub.2021.10.035. Epub 2021 Nov 11. PMID: 34767768.
Copy Download .nbib Format: NLM
CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study.

Journal for immunotherapy of cancer

Sanborn RE, Hamid O, de Vries EG, Ott PA, Garcia-Corbacho J, Boni V, Bendell J, Autio KA, Cho DC, Plummer R, Stroh M, Lu L, Thistlethwaite F.
PMID: 34301808
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002446.

BACKGROUND: Probody® therapeutics are antibody prodrugs designed to be activated by tumor-associated proteases. This conditional activation restricts antibody binding to the tumor microenvironment, thereby minimizing 'off-tumor' toxicity. Here, we report the phase 1 data from the first-in-human study of...

Cite
Sanborn RE, Hamid O, de Vries EG, et al. CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study. J Immunother Cancer. 2021;9(7)doi: 10.1136/jitc-2021-002446.
Sanborn, R. E., Hamid, O., de Vries, E. G., Ott, P. A., Garcia-Corbacho, J., Boni, V., Bendell, J., Autio, K. A., Cho, D. C., Plummer, R., Stroh, M., Lu, L., & Thistlethwaite, F. (2021). CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study. Journal for immunotherapy of cancer, 9(7), . https://doi.org/10.1136/jitc-2021-002446
Sanborn, Rachel E, et al. "CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study." Journal for immunotherapy of cancer vol. 9,7 (2021). doi: https://doi.org/10.1136/jitc-2021-002446
Sanborn RE, Hamid O, de Vries EG, Ott PA, Garcia-Corbacho J, Boni V, Bendell J, Autio KA, Cho DC, Plummer R, Stroh M, Lu L, Thistlethwaite F. CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study. J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002446. PMID: 34301808; PMCID: PMC8311331.
Copy Download .nbib Format: NLM
Science as a classed and gendered endeavor: Persistence of two White female first‐generation college students within an undergraduate science context.

Wilson RachelE, Kittleson Julie.
UIID-AD: 2523
2013;50:802-825. doi: 10.1002/tea.21087.

As colleges and universities aim for greater diversity in their undergraduate populations, one population researchers consider is first-generation students, or students whose parents do not have a college education. The research reported here addresses first-generation college students’ discipline of...

Cite
Wilson RachelE, Kittleson Julie. Science as a classed and gendered endeavor: Persistence of two White female first‐generation college students within an undergraduate science context. 2013;50:802-825doi: 10.1002/tea.21087.
Wilson, R. a. c. h. e. l. E., & Kittleson, J. u. l. i. e. (2013). Science as a classed and gendered endeavor: Persistence of two White female first‐generation college students within an undergraduate science context. 50802-825. https://doi.org/10.1002/tea.21087
Wilson, Rachel E, and Kittleson, Julie. "Science as a classed and gendered endeavor: Persistence of two White female first‐generation college students within an undergraduate science context." vol. 50 (2013): 802-825. doi: https://doi.org/10.1002/tea.21087
Wilson RachelE, Kittleson Julie. Science as a classed and gendered endeavor: Persistence of two White female first‐generation college students within an undergraduate science context. 2013;50:802-825. doi: 10.1002/tea.21087. UIID-AD: 2523.
Copy Download .nbib Format: NLM
Showing 1441 to 1447 of 1447 entries